Australia's most trusted
source of pharma news
Saturday, 20 April 2024
Posted 18 July 2022 PM
GSK and its spin off, Haleon, have unveiled their future identities with the company's official demerger scheduled to take place in a matter of hours.
While the pharmaceutical and vaccine arm of the business will keep the GSK moniker as it forges a separate path, Haleon will become the world's largest consumer healthcare business.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.